Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LIPOLASIC 2 mg/g GEL OFTALMICO - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LIPOLASIC 2 mg/g GEL OFTALMICO

Approved

STANDARD

LIPOLASIC 2 mg/g GEL OFTALMICO

Laboratoire Chauvin🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 12, 2020
Approval ID: cef010b6240ae357
Company: Laboratoire Chauvin
Type: Standard

Approval Details

Approval Id: cef010b6240ae357
Drug Cima Aemps Name: LIPOLASIC 2 mg/g GEL OFTALMICO
Register Number: 3400935931016
Holder Company Name: Laboratoire Chauvin
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/laboratoire-chauvin
Authorization Date: 2020-07-12
Dosage Form: GEL OFTÁLMICO
Dose: 2 MG/G
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratoire Chauvin
Company Detail Path: /organization/laboratoire-chauvin

Company Information

Pharmaceutical Company Name: Laboratoire Chauvin
Name En: Laboratoire Chauvin
Country Name: France
City Name: aubenas,auvergne rhone alpes,country_fr
Address: ZONE INDUSTRIELLE DE RIPOTIER

Active Ingredients

CARBOMERO

2 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 12, 2020

Approval ID

cef010b6240ae357

Type

Standard

Back to CIMA-AEMPS Approvals